An Active-Controlled Early Phase Study of Elpipodect (MK-8189) in Adults With Schizophrenia (MK-8189-005)

Clinical trial NCT03055338 · COMPLETED

Trial details

NCT number: NCT03055338
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Schizophrenia, Acute Episode

Start date: 2017-03-08
Primary completion: 2018-01-09
Enrollment: 224

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.